Lifetime risk of solid tumors and leukemia in Down Syndrome: a population-based Swedish matched cohort study
We present the most comprehensive profile of cancer risk in Down syndrome, aiming to guide clinical practices, encourage tailored surveillance recommendations, and incite research on chromosome 21's role in oncogenesis.
Authors
- Benedicte Bang (ORCID: https://orcid.org/0000-0001-6907-4954)
- Alexandra Wachtmeister (ORCID: https://orcid.org/0000-0003-0553-1460)
- Anna Skarin Nordenvall (ORCID: https://orcid.org/0000-0003-3034-9222)
- Giorgio Tettamanti
- Bertil Johansson (ORCID: https://orcid.org/0000-0001-8829-4813)
- Anna Martling (ORCID: https://orcid.org/0000-0001-5998-4735)
- I. Nordgren (ORCID: https://orcid.org/0009-0009-3000-361X)
- Y. Lu
- Ann Nordgren
Institutions
- Karolinska University Hospital (SE)
- Sahlgrenska University Hospital (SE)
- Karolinska Institutet (SE)
- Centre de recherche en Epidémiologie et Santé des Populations (FR)
- Skåne University Hospital (SE)
Publication Details
- Journal
- British Journal of Cancer
- Published
- 2025-12-26
- DOI
- https://doi.org/10.1038/s41416-025-03318-5
- Primary Topic
- Down syndrome and intellectual disability research
- Type
- article
- Field-Weighted Citation Impact
- 0.00